ENTITY

MapLight Therapeutics (MPLT US)

11
Analysis
Health Care • United States
MapLight Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on improving the lives of patients suffering from debilitating central nervous system disorders. MapLight Therapeutics operates in the United States.
more
Exchange Announcement • 24 Sep 2026 04:22

424B3 | Prospectus

Exchange Announcement • 19 Sep 2026 04:15

S-1/A | IPO Registration (Amendment)

Exchange Announcement • 10 Sep 2026 05:28

S-1 | IPO Registration

Exchange Announcement • 13 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 27 Jul 2026 19:07

Current Report (Form 8-K | Period ending 2026-07-27)

x